Amphastar Pharmaceuticals, Inc. (AMPH)
Company Info
US03209R1032
03209R103
Jun 25, 2014
Highlights
$1.96B
$3.01
13.57
2.77
$721.15M
$374.85M
$267.92M
$36.56 - $65.92
$58.20
13.18%
9.71
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Amphastar Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Amphastar Pharmaceuticals, Inc. had a return of -36.22% year-to-date (YTD) and -34.75% in the last 12 months. Over the past 10 years, Amphastar Pharmaceuticals, Inc. had an annualized return of 12.63%, outperforming the S&P 500 benchmark which had an annualized return of 11.01%.
AMPH
-36.22%
-10.67%
-1.50%
-34.75%
15.04%
12.63%
^GSPC (Benchmark)
23.11%
-0.36%
7.02%
23.15%
12.80%
11.01%
Monthly Returns
The table below presents the monthly returns of AMPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -13.73% | -12.72% | -5.71% | -6.06% | 2.62% | -5.50% | 8.80% | 11.99% | -0.43% | 4.12% | -10.57% | -36.22% | |
| 2023 | 7.99% | 5.29% | 17.70% | -4.61% | 24.04% | 29.52% | 5.60% | -12.16% | -13.73% | -1.57% | 24.41% | 9.82% | 120.74% |
| 2022 | -0.86% | 20.01% | 29.56% | -1.20% | 4.71% | -6.33% | 7.47% | -20.83% | -5.07% | 9.96% | -4.56% | -4.98% | 20.31% |
| 2021 | -9.60% | -3.58% | 4.51% | -5.02% | 8.74% | 6.55% | 3.92% | -6.16% | -3.31% | -1.74% | 4.71% | 19.07% | 15.81% |
| 2020 | -1.97% | -18.61% | -3.57% | 14.22% | 9.97% | 20.49% | -10.86% | 1.80% | -8.00% | 4.48% | -9.34% | 13.23% | 4.25% |
| 2019 | 14.37% | 9.18% | -17.79% | 5.68% | -10.84% | 9.66% | -4.55% | 11.46% | -11.71% | -2.60% | 1.01% | -1.13% | -3.07% |
| 2018 | -3.12% | -1.50% | 2.12% | 1.81% | -17.23% | -3.42% | 14.35% | 8.77% | 1.37% | -6.70% | 21.00% | -8.38% | 3.43% |
| 2017 | -14.50% | -1.78% | -6.27% | 4.14% | 13.05% | 4.63% | -3.25% | -7.35% | 11.62% | 1.12% | 8.41% | -1.79% | 4.45% |
| 2016 | -15.32% | -12.61% | 13.96% | 2.50% | 27.89% | 2.48% | 0.37% | 17.43% | -0.16% | -4.38% | 11.74% | -9.13% | 29.44% |
| 2015 | 4.48% | 15.42% | 6.86% | -3.34% | 6.09% | 14.60% | -7.51% | -20.85% | -9.17% | 1.28% | 29.65% | -7.30% | 22.57% |
| 2014 | 14.40% | -11.29% | 36.15% | -3.64% | -12.96% | 2.86% | 11.31% | 32.69% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AMPH is 12, meaning it’s performing worse than 88% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Amphastar Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amphastar Pharmaceuticals, Inc. was 49.92%, occurring on Mar 20, 2020. Recovery took 456 trading sessions.
The current Amphastar Pharmaceuticals, Inc. drawdown is 39.31%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -49.92% | Mar 4, 2019 | 266 | Mar 20, 2020 | 456 | Jan 10, 2022 | 722 |
| -43.39% | Nov 18, 2016 | 78 | Mar 14, 2017 | 420 | Nov 9, 2018 | 498 |
| -43.09% | Aug 9, 2023 | 230 | Jul 9, 2024 | — | — | — |
| -42.11% | Jun 26, 2015 | 170 | Feb 29, 2016 | 115 | Aug 11, 2016 | 285 |
| -35.49% | Apr 14, 2022 | 144 | Nov 8, 2022 | 109 | Apr 18, 2023 | 253 |
Volatility
Volatility Chart
The current Amphastar Pharmaceuticals, Inc. volatility is 9.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Amphastar Pharmaceuticals, Inc. compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for AMPH in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, AMPH has a PE value of 13.6. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for AMPH in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, AMPH has a PEG value of 2.8. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Amphastar Pharmaceuticals, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |